Ayça Dedeoglu Erdogan

Ayça Dedeoglu Erdogan

Auto-generated profile, based on publicly available information

Ayça Dedeoglu Erdogan

YEDİTEPE ÜNİVERSİTESİ, ECZACILIK FAKÜLTESİ

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 May 2021 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
MKMeric Koksal
Meric Koksal
ADAyca Dedeoglu‐Erdogan
Ayca Dedeoglu‐Erdogan
MBMarwa Bader
Marwa Bader
EGEnise E. Gurdal
Enise E. Gurdal
Wolfgang SipplWolfgang Sippl
Wolfgang Sippl
TCTurgay Celik
Turgay Celik

24 September 2024 in Fabad Journal of Pharmaceutical Sciences
Verified
Journal Article
Closed access
AEAyça Dedeoglu Erdogan
Ayça Dedeoglu Erdogan
AMArmanç Mat
Armanç Mat
EGEnise Ece Gürdal
Enise Ece Gürdal
MKMeric Koksal
Meric Koksal
Drug discovery as an important scientific area that serves human health, requires continuous advancement for improved quality of life and survival rates. However, drug discovery is a long and expensive process. The studies aimed at dealing with these problems have enabled to combination of AI with drug development stages. For every step of the R&D process, AI plays a vital role in facilitating and accelerating the work. Firstly, AI methods (deep learning and convolutional neural networks) help predict the 3D structure of an unresolved protein making it easier for the rational design of compounds to target a specific protein among other potential outcomes. After estimation of the protein structure of interest, it is also possible to determine the protein-ligand interactions by utilizing AI technologies like random forest. The other stage, namely finding the hit compounds is also possible through AI-assisted QSAR models such as deep neural networks. Besides, there are many AI methods (k-nearest neighbor and support vector machines) for ADMET prediction to optimize lead compounds. Finally, AI techniques also aid in choosing the most suitable synthesis plan. In the light of the latest advances, AI has become the focus of the pharmaceutical industry. However, despite the potential benefits of AI in drug discovery, several challenges must be considered including the availability of suitable data and bioethical issues. This article provides a comprehensive review of the benefits and applications of AI in various stages of drug discovery. In addition, the open-source act model and bioethical issues are also discussed.